Tags

Type your tag names separated by a space and hit enter

Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence.
Urology. 2006 May; 67(5):965-9.U

Abstract

OBJECTIVES

To examine a new prosthesis, the Adjustable Continence Therapy (ProACT), to determine its ability to treat effectively post radical prostatectomy urinary incontinence. Urinary incontinence is one of the most significant complications of radical prostatectomy. Although the artificial urinary sphincter (AUS) is considered the standard treatment for this condition, many men seek a simpler and less expensive treatment option.

METHODS

From November 2000 to March 2004, 25 patients with severe post radical prostatectomy urinary incontinence were treated using the ProACT device. The preoperative evaluation included pad count, Valsalva leak point pressure determination, and Incontinence Quality-of-Life scores. In the follow-up, the same parameters, as well as complications, were analyzed and compared with the baseline measurements to assess the efficacy.

RESULTS

The follow-up period was 6 to 48 months (mean 22.4). Of the 25 patients, 23 had follow-up data available for analysis. The improvements in pad count, Incontinence Quality-of-Life score, and Valsalva leak point pressures from baseline to the last follow-up examination were all significant (P <0.05). Overall, of the 23 patients followed up, 15 (65.2%) were continent using 0 to 1 pad daily and satisfied, 3 (13%) were improved but unsatisfied, and 5 (22%) did not have any improvement. Balloon adjustments were performed in all patents to achieve continence. Revision surgery was required in 4 (17%) of 23 patients.

CONCLUSIONS

The use of ProACT represents a safe and effective treatment for post radical prostatectomy incontinence with a good degree of patient satisfaction and a low complication rate. Postoperative adjustments were necessary in most patients and were undertaken as a simple outpatient visit.

Authors+Show Affiliations

Department of Urology, São Paulo University, São Paulo, Brazil. flaviotrigo@uol.com.brNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16698356

Citation

Trigo-Rocha, Flavio, et al. "Prospective Study Evaluating Efficacy and Safety of Adjustable Continence Therapy (ProACT) for Post Radical Prostatectomy Urinary Incontinence." Urology, vol. 67, no. 5, 2006, pp. 965-9.
Trigo-Rocha F, Gomes CM, Pompeo AC, et al. Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence. Urology. 2006;67(5):965-9.
Trigo-Rocha, F., Gomes, C. M., Pompeo, A. C., Lucon, A. M., & Arap, S. (2006). Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence. Urology, 67(5), 965-9.
Trigo-Rocha F, et al. Prospective Study Evaluating Efficacy and Safety of Adjustable Continence Therapy (ProACT) for Post Radical Prostatectomy Urinary Incontinence. Urology. 2006;67(5):965-9. PubMed PMID: 16698356.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence. AU - Trigo-Rocha,Flavio, AU - Gomes,Cristiano Mendes, AU - Pompeo,Antonio Carlos Lima, AU - Lucon,Antonio Marmo, AU - Arap,Sami, PY - 2005/04/26/received PY - 2005/10/11/revised PY - 2005/11/03/accepted PY - 2006/5/16/pubmed PY - 2006/5/26/medline PY - 2006/5/16/entrez SP - 965 EP - 9 JF - Urology JO - Urology VL - 67 IS - 5 N2 - OBJECTIVES: To examine a new prosthesis, the Adjustable Continence Therapy (ProACT), to determine its ability to treat effectively post radical prostatectomy urinary incontinence. Urinary incontinence is one of the most significant complications of radical prostatectomy. Although the artificial urinary sphincter (AUS) is considered the standard treatment for this condition, many men seek a simpler and less expensive treatment option. METHODS: From November 2000 to March 2004, 25 patients with severe post radical prostatectomy urinary incontinence were treated using the ProACT device. The preoperative evaluation included pad count, Valsalva leak point pressure determination, and Incontinence Quality-of-Life scores. In the follow-up, the same parameters, as well as complications, were analyzed and compared with the baseline measurements to assess the efficacy. RESULTS: The follow-up period was 6 to 48 months (mean 22.4). Of the 25 patients, 23 had follow-up data available for analysis. The improvements in pad count, Incontinence Quality-of-Life score, and Valsalva leak point pressures from baseline to the last follow-up examination were all significant (P <0.05). Overall, of the 23 patients followed up, 15 (65.2%) were continent using 0 to 1 pad daily and satisfied, 3 (13%) were improved but unsatisfied, and 5 (22%) did not have any improvement. Balloon adjustments were performed in all patents to achieve continence. Revision surgery was required in 4 (17%) of 23 patients. CONCLUSIONS: The use of ProACT represents a safe and effective treatment for post radical prostatectomy incontinence with a good degree of patient satisfaction and a low complication rate. Postoperative adjustments were necessary in most patients and were undertaken as a simple outpatient visit. SN - 1527-9995 UR - https://www.unboundmedicine.com/medline/citation/16698356/Prospective_study_evaluating_efficacy_and_safety_of_Adjustable_Continence_Therapy__ProACT__for_post_radical_prostatectomy_urinary_incontinence_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0090-4295(05)01623-7 DB - PRIME DP - Unbound Medicine ER -